claim: proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 6 infection
evidence_1: treatment with proton pump inhibitors increases the risk of secondary infections and ards in hospitalized patients with covid-19: coincidence or underestimated risk factor?.", "based on our pooled analysis of available data, the use of proton pump inhibitors (ppis) seems to be associated with an enhanced risk of severity and mortality from covid-19 infection.", "view large image figure viewer download hi-res image download (ppt) based on our pooled analysis of available data, the use of proton pump inhibitors (ppis) seems to be associated with an enhanced risk of severity and mortality from covid-19 infection.", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (covid-19) infection.")